Search

Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents

Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 13 Year: 2019 Page: 1121-1128
Author(s): Gulcin Tugcu,Hande Sipahi,Ahmet Aydin

Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their StructuralDiversity and Mechanism of Action

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 1 Year: 2023 Page: 15-36
Author(s):

New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2018 Page: 295-301
Author(s): Shabnam Farzaneh,Elnaz Zeinalzadeh,Bahram Daraei,Soraya Shahhosseini,Afshin Zarghi

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 4 Issue: 6 Year: 2004 Page: i-i
Author(s): Jean-Michel Dogne, Xavier de Leval

Editorial [Hot Topic: The Administration of Non-Steroidal Anti-Inflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors in Dentistry (Executive Editor: Saynur Vardar)]

Journal: Current Pharmaceutical Design
Volume: 11 Issue: 1 Year: 2005 Page: 1735-1736
Author(s): Saynur Vardar

The Role of COX-2 in Oral Cancer Development, and Chemoprevention/ Treatment of Oral Cancer by Selective COX-2 Inhibitors

Journal: Current Pharmaceutical Design
Volume: 11 Issue: 1 Year: 2005 Page: 1771-1777
Author(s): Z. Wang

Cardiovascular and Renovascular Implications of COX-2 Inhibition

Journal: Current Pharmaceutical Design
Volume: 10 Issue: 6 Year: 2004 Page: 603-611
Author(s): Emma A. Meagher

Anti-Inflammatory/Analgesic

Journal: Current Bioactive Compounds
Volume: 1 Issue: 2 Year: 2005 Page: 135-139
Author(s): Bentham Science Publishers

Role of Cyclooxygenases in Angiogenesis

Journal: Current Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2000 Page: 1163-1170
Author(s): K. M. Leahy, A. T. Koki, J. L. Masferrer

COX-2 Inhibition, H. pylori Infection and the Risk of Gastrointestinal Complications

Journal: Current Pharmaceutical Design
Volume: 9 Issue: 2 Year: 2003 Page: 2213-2219
Author(s): Francis K.L. Chan